Market capitalization | €67.28b |
Enterprise Value | €75.09b |
PER (TTM) P/E ratio | 24.71 |
EV/FCF (TTM) EV/FCF | 34.01 |
EV/Sales (TTM) EV/Sales | 3.61 |
P/S ratio (TTM) P/S ratio | 3.23 |
P/B ratio (TTM) P/B ratio | 2.40 |
Dividend yield | 1.42% |
Last dividend (FY23) | €2.20 |
Activate alerts on the share price, dividend yield, valuation (e.g. P/E ratio or EV/sales) or strategy scores and sit back and relax.
17 Analysts have issued a Merck forecast:
17 Analysts have issued a Merck forecast:
Mar '24 |
+/-
%
|
||
Turnover | 20,820 20,820 |
7%
7%
|
|
Gross income | 12,081 12,081 |
13%
13%
|
|
EBITDA | 6,004 6,004 |
19%
19%
|
EBIT (operating result) EBIT | 4,126 4,126 |
25%
25%
|
Net profit | 2,722 2,722 |
16%
16%
|
Figures in millions EUR.
If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.
Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, and Performance Materials. The Healthcare sector discovers, develops, and produces prescription medicines used to treat cancer, multiple sclerosis, and infertility. The Life Science sector provides scientists with laboratory materials, technologies, and services. The Performance Materials sector offers specialty chemicals and materials for demanding applications. The firm offers pharma and biopharma manufacturing, pharmaceutical research, pharma quality control, and government and academic research services. The company was founded by Friedrich Jacob Merck in 1668 and is headquartered in Darmstadt, Germany.
Head office | Germany |
CEO | Belén López |
Employees | 62,908 |
Founded | 1995 |
Website | www.merckgroup.com |
StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.